Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2018 |
| Author/s | |
| Publication date | October 15, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |